Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Completed 8Unknown 4Not yet recruiting 3Active not recruiting 3Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 9Pancreatic Neoplasms 3Biliary Tract Neoplasms 3Locally Advanced Gastric Cancer 2Cholangiocarcinoma 2Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1Pancoast Syndrome 1Neoplasms 1Gastric Cancer Peritoneal Metastases 1Gastric Adenocarcinoma 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Efficacy and Safety 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of the Stomach 1

Interventions

Gemcitabine 7Cisplatin 6Oxaliplatin 5Fluorouracil 4lenvatinib 3envafolimab 3S 1 (combination) 3Capecitabine 3toripalimab 2pembrolizumab 2Leucovorin 2Irinotecan 2Folfox protocol 2tislelizumab 1tegafur-gimeracil-oteracil 1surufatinib 1pertuzumab 1mitazalimab 1durvalumab 1disitamab vedotin 1camrelizumab 1anlotinib 1Simvastatin 1Self Expandable Metallic Stents 1Bevacizumab 1Albumin-Bound Paclitaxel 1Actigraphy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Biliary Tract Neoplasms × S 1 (combination) × Clear all
NCT07561775 2026-05-01

Adebrelimab Plus S-1 for Resected Cholangiocarcinoma

Tongji Hospital

Phase 2 Not yet recruiting
40 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT06903273 2025-03-30

TisGCS for BTC

National Cheng-Kung University Hospital

Phase 2 Not yet recruiting
35 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT06662877 2024-10-29

Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line Treatment

Sun Yat-sen University

Phase 2/3 Not yet recruiting
206 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡